Acadia Pharmaceuticals buy Citigroup Inc.

Summary

This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -12.08%. This prediction currently runs until 07.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Acadia Pharmaceuticals	-3.689%	-3.689%
iShares Core DAX®	2.554%	0.562%
iShares Nasdaq 100	2.742%	-0.599%
iShares Nikkei 225®	6.584%	4.336%
iShares S&P 500	1.930%	-0.507%